Condition: Hypercholesterolemia, Autosomal Dominant · Hypercholesterolemia, Autosomal Recessive · Familial Combined Hypercholesterolemia · Sponsor: Abu Dhabi Health Services Company
This pilot study investigates integrating whole genome sequencing and digital twin technology for managing hypercholesterolemia in Abu Dhabi clinics. It aims to establish protocols for larger future studies and incorporate genomic insights into routine medical care.
This description comes directly from the study's public registry record.
Alina Naeem, MBBS · +97124102534 · alnaeem@seha.ae
Mhy-Lanie Adduru, MD · +14088311991 · mhy-lanie@predictivcare.com
Always discuss trial participation with your own doctor first.
| Abu Dhabi Health Research Center | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06535542